Aetna modified CPB 0800 for Dupuytren's contracture treatments, effective November 22, 2025. Here's what billing teams need to do.
Aetna, a CVS Health company, updated Clinical Policy Bulletin 0800, which governs coverage for Dupuytren's contracture procedures across commercial medical plans. The policy defines medical necessity criteria for percutaneous needle aponeurotomy (CPT 26040), ortho-voltage radiation (CPT 77401), intralesional glucocorticoid injection (CPT 20550), and collagenase injection (CPT 20527 and 26341). It also draws a hard line on what Aetna calls experimental—a list that now includes 16 distinct interventions, several with specific CPT codes your team may already be billing.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Dupuytren's Contracture: Treatments |
| Policy Code | CPB 0800 |
| Change Type | Modified |
| Effective Date | November 22, 2025 |
| Impact Level | Medium |
| Specialties Affected | Orthopedic Surgery, Hand Surgery, Plastic Surgery, Physical Medicine & Rehabilitation, Radiation Oncology |
| Key Action | Audit your charge capture for CPT 26040, 77401, 20527, and 20550 against the updated medical necessity criteria before submitting claims for dates of service on or after November 22, 2025. |
Aetna Dupuytren's Contracture Coverage Criteria and Medical Necessity Requirements 2025
CPB 0800 Aetna's Dupuytren's contracture coverage policy sets distinct criteria for each covered intervention. These are not interchangeable. The wrong treatment for the wrong stage will get denied.
Intralesional Glucocorticoid Injection (CPT 20550)
Aetna covers intralesional glucocorticoid injection as medically necessary for two specific indications only: local tenderness from tenosynovitis, or rapidly growing palmar nodules. Both must occur in early-stage disease. If your documentation doesn't reflect one of those two indications explicitly, expect a claim denial.
Ortho-Voltage Radiation (CPT 77401)
Aetna covers ortho-voltage radiation for early-stage Dupuytren's contracture—specifically stage N or stage N/I. Stage N means the patient has nodules or cords with no extension deficit. Stage N/I means a flexion deformity of 10 degrees or less. Document the stage explicitly in the clinical note. "Early-stage Dupuytren's" alone is not enough.
Percutaneous Needle Aponeurotomy (CPT 26040)
This is the one with the most specific criteria. Aetna considers percutaneous needle aponeurotomy (also called percutaneous needle fasciotomy) medically necessary only when all four of the following are true:
| # | Covered Indication |
|---|---|
| 1 | The patient is an adult |
| 2 | There is a finger flexion contracture with a palpable cord in a metacarpophalangeal (MCP) joint or a proximal interphalangeal (PIP) joint |
| 3 | The contracture is at least 20 degrees |
| 4 | The patient has a positive table top test—defined as the inability to simultaneously place the affected finger(s) and palm flat against a table |
All four criteria must be documented. Miss one, and you've handed Aetna a reason to deny. The table top test result in particular needs to appear in the clinical record, not just in the provider's head.
Collagenase Clostridium Histolyticum (CPT 20527, 26341)
Aetna covers collagenase injection and post-injection manipulation under a separate policy—CPB 1061. CPB 0800 cross-references CPB 1061 for this treatment. If your practice bills CPT 20527 (injection) or CPT 26341 (manipulation, palmar fascial cord post-enzyme injection), confirm coverage criteria against CPB 1061, not CPB 0800.
The Aetna Dupuytren's contracture coverage policy does not explicitly state prior authorization requirements within CPB 0800. That said, procedures like CPT 26040 and CPT 77401 frequently trigger prior auth edits at the plan level. Check your specific Aetna contract and plan type before assuming these are prior authorization-exempt. If you're billing for a commercial fully-insured plan, prior auth requirements may vary by state.
Aetna Dupuytren's Contracture Exclusions and Non-Covered Indications
This is where CPB 0800 gets specific—and where your billing team is most at risk. Aetna lists 16 interventions as experimental, investigational, or unproven. Several of these have CPT or HCPCS codes that could end up on a claim if your charge capture isn't clean.
The full exclusion list:
| # | Excluded Procedure |
|---|---|
| 1 | Anti-tumor necrosis factor therapy (HCPCS J0139, J0717, J1438, J1602, J1745, and biosimilar codes Q5103, Q5104, Q5109, Q5140–Q5145, S9359) |
| 2 | Autologous fat grafting (CPT 15769, 15770, 15773, +15774) |
| 3 | Collagenase nanocapsules |
| 4 | Combined percutaneous needle aponeurotomy and lipografting |
| 5 | Continuous slow skeletal traction (CPT 97012) |
| 6 | Cryopreserved placental membrane |
| 7 | Dermofasciectomy as primary treatment for Dupuytren's disease |
| 8 | Digit Widget for PIP flexion contractures |
| 9 | Dynamic manugraphy for outcome evaluation of aponeurectomy |
| 10 | Extracorporeal shock wave therapy (CPT 0101T, 28890) |
| 11 | Interferon therapy (HCPCS J1826, J1830, J9212, J9213, J9214, J9215, J9216, Q3027, Q3028, S0145, S0148, S9559) |
| 12 | Middle-phalanx excision and ligament reconstruction |
| 13 | Night-time splinting/orthosis after fasciectomy or dermofasciectomy |
| 14 | Peri-operative 192-Ir high dose rate brachytherapy (HCPCS C1717) |
| 15 | Sono-Bath percutaneous sonography-guided technique (CPT 76942) |
| 16 | Ultrasound therapy (CPT 97035) |
The real issue here is the fat grafting codes. CPT 15769, 15770, 15773, and add-on code +15774 are used across multiple surgical contexts. If your hand surgeon performs lipografting alongside needle aponeurotomy as part of a combined procedure, Aetna will not reimburse it for this diagnosis. Both components of that combined procedure are on the experimental list.
The same goes for extracorporeal shock wave therapy. CPT 0101T and 28890 are covered for other musculoskeletal indications under some Aetna plans—but not for Dupuytren's contracture under CPB 0800.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Intralesional glucocorticoid injection for tenosynovitis or rapidly growing palmar nodules (early-stage) | Covered | CPT 20550 | Must document early-stage disease and specific indication |
| Ortho-voltage radiation, stage N or N/I Dupuytren's | Covered | CPT 77401 | Stage must be documented; N = no extension deficit, N/I = ≤10° deficit |
| Percutaneous needle aponeurotomy / fasciotomy | Covered | CPT 26040 | All four criteria required: adult patient, palpable cord at MCP or PIP, ≥20° contracture, positive table top test |
| Collagenase injection and post-injection manipulation | Covered (see CPB 1061) | CPT 20527, 26341 | Governed by CPB 1061, not CPB 0800 |
| Fasciectomy (palmar, partial palmar) | Related/Other | CPT 26121, 26123, 26125, 26045 | Listed as related codes—verify coverage under separate criteria |
| Autologous fat grafting / lipografting | Experimental | CPT 15769, 15770, 15773, +15774 | Not covered for Dupuytren's under CPB 0800 |
| Combined needle aponeurotomy + lipografting | Experimental | CPT 26040 + 15773 | Both components excluded when combined |
| Extracorporeal shock wave therapy | Experimental | CPT 0101T, 28890 | Not covered regardless of energy level |
| Anti-tumor necrosis factor therapy | Experimental | HCPCS J0139, J1438, J1745, biosimilar Q codes | Multiple TNF-alpha biologics and biosimilars excluded |
| Interferon therapy | Experimental | HCPCS J1826, J9212–J9216, Q3027, Q3028, S0145, S0148 | All interferon formulations excluded |
| Continuous slow skeletal traction | Experimental | CPT 97012 | Mechanical traction for Dupuytren's is not covered |
| Ultrasound therapy | Experimental | CPT 97035 | Therapeutic ultrasound excluded |
| Sono-Bath / sonography-guided technique | Experimental | CPT 76942 | Ultrasonic needle guidance for Dupuytren's is not covered |
| Peri-operative 192-Ir brachytherapy | Experimental | HCPCS C1717 | High dose rate brachytherapy excluded post-aponeurotomy |
| Night-time splinting after fasciectomy | Experimental | — | No specific HCPCS listed; coverage denied as standard post-op protocol |
| Dermofasciectomy (primary treatment) | Experimental | — | Not covered as primary treatment; check if secondary indications apply |
| Digit Widget for PIP flexion contractures | Experimental | — | No specific code listed in policy |
| Cryopreserved placental membrane | Experimental | — | No specific code listed |
| Dynamic manugraphy | Experimental | — | No specific code listed |
| Middle-phalanx excision and ligament reconstruction | Experimental | — | No specific code listed |
Aetna Dupuytren's Contracture Billing Guidelines and Action Items 2025
This update took effect November 22, 2025. If you're billing for dates of service on or after that date, these steps apply now.
| # | Action Item |
|---|---|
| 1 | Audit your charge capture for CPT 26040 immediately. Percutaneous needle aponeurotomy has four hard criteria. Pull your last 90 days of claims with ICD-10 M72.0 or M24.54x and confirm each claim has documentation of the palpable cord, the degree of contracture (≥20°), joint location (MCP or PIP), and the table top test result. Any claim missing one of those elements is a denial waiting to happen. |
| 2 | Separate out combined aponeurotomy-lipografting cases. If your hand surgeons perform percutaneous needle aponeurotomy combined with lipografting, that combined procedure is experimental under CPB 0800. Don't bill CPT 26040 alongside 15769, 15770, 15773, or +15774 for Aetna commercial plans. This needs a conversation with your hand surgery team before the next case is scheduled. |
| 3 | Flag CPT 77401 claims for radiation oncology. Ortho-voltage radiation is covered—but only for stage N or stage N/I. Your radiation oncology billing team needs the Dupuytren's stage in the clinical record before submitting. "Early-stage" documented in the referring note is not sufficient. The radiation oncology note must reflect the staging criteria. |
| 4 | Route collagenase claims to CPB 1061, not CPB 0800. If your practice bills CPT 20527 or CPT 26341 for Aetna commercial patients, your prior authorization requests and appeals should reference CPB 1061. Citing CPB 0800 on a collagenase claim creates a documentation mismatch that can slow reimbursement or trigger a denial. |
| 5 | Remove shock wave therapy from your Dupuytren's charge sets. CPT 0101T and 28890 are explicitly experimental under this coverage policy. If either code is included in a Dupuytren's order set or charge capture template, remove it now. This applies regardless of whether shock wave is covered under other Aetna policies for other diagnoses—for M72.0 and M24.54x, it does not get covered. |
| 6 | Update your denial management filters. Add CPT 0101T, 28890, 97012, 97035, 76942, and the fat grafting codes (15769, 15770, 15773, +15774) to your Aetna Dupuytren's denial watch list. If any of these codes are denied with a Dupuytren's diagnosis on or after November 22, 2025, the denial is correct under CPB 0800. Appeals are unlikely to succeed without new clinical evidence challenging Aetna's experimental designation. |
| 7 | Verify prior authorization requirements by plan. CPB 0800 doesn't spell out prior auth rules within the bulletin. But CPT 26040 and CPT 77401 are the kind of procedures that often sit on Aetna's PA list at the plan level. Confirm requirements for each patient's specific plan before scheduling. If you're uncertain about how this coverage policy applies to your payer mix, talk to your compliance officer before the November 22, 2025 effective date has passed too far behind you. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Dupuytren's Contracture Under CPB 0800
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 20527 | CPT | Injection, enzyme (e.g., collagenase), palmar fascial cord — Dupuytren's contracture (see CPB 1061) |
| 26040 | CPT | Fasciotomy, palmar (e.g., Dupuytren's contracture); percutaneous |
| 26341 | CPT | Manipulation, palmar fascial cord post enzyme injection (e.g., collagenase) (see CPB 1061) |
| 77401 | CPT | Radiation treatment delivery, superficial and/or ortho voltage, per day |
Other CPT Codes Related to CPB 0800
| Code | Type | Description |
|---|---|---|
| 20550 | CPT | Injection(s); single tendon sheath, or ligament, aponeurosis (e.g., plantar "fascia") |
| 26045 | CPT | Fasciotomy, palmar (e.g., Dupuytren's contracture); open, partial |
| 26121 | CPT | Fasciectomy, palm only, with or without Z-plasty, other local tissue rearrangement, or skin grafting |
| 26123 | CPT | Fasciectomy, partial palmar with release of single digit including proximal interphalangeal joint |
| 26125 | CPT | Fasciectomy, partial palmar with release of single digit including proximal interphalangeal joint (each additional digit) |
Not Covered / Experimental CPT Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| 0101T | CPT | Extracorporeal shock wave, musculoskeletal system, NOS, high energy | Experimental under CPB 0800 |
| 15769 | CPT | Grafting of autologous soft tissue, other, harvested by direct excision (e.g., fat, dermis, fascia) | Experimental — autologous fat grafting |
| 15770 | CPT | Graft; derma-fat-fascia | Experimental — autologous fat grafting |
| 15773 | CPT | Grafting of autologous fat harvested by liposuction technique to face, eyelids, mouth, neck, ears, or lips | Experimental — autologous fat grafting |
| +15774 | CPT | Each additional 25 cc injectate (add-on) | Experimental — autologous fat grafting |
| 28890 | CPT | Extracorporeal shock wave, high energy, performed by physician or other qualified health care professional | Experimental under CPB 0800 |
| 76942 | CPT | Ultrasonic guidance for needle placement, imaging supervision and interpretation | Experimental — Sono-Bath/sonography-guided technique |
| 97012 | CPT | Application of a modality; traction, mechanical | Experimental — continuous slow skeletal traction |
| 97035 | CPT | Application of a modality; ultrasound, each 15 minutes | Experimental — ultrasound therapy |
Not Covered / Experimental HCPCS Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| C1717 | HCPCS | Brachytherapy source, nonstranded, high dose rate iridium-192, per source | Experimental — peri-operative 192-Ir HDR brachytherapy |
| J0139 | HCPCS | Injection, adalimumab, 1 mg | Experimental — anti-TNF therapy |
| J0717 | HCPCS | Injection, certolizumab pegol, 1 mg | Experimental — anti-TNF therapy |
| J1438 | HCPCS | Injection, etanercept, 25 mg | Experimental — anti-TNF therapy |
| J1602 | HCPCS | Injection, golimumab, 1 mg, for intravenous use | Experimental — anti-TNF therapy |
| J1745 | HCPCS | Injection, infliximab, excludes biosimilar, 10 mg | Experimental — anti-TNF therapy |
| J1826 | HCPCS | Injection, interferon beta-1a, 30 mcg | Experimental — interferon therapy |
| J1830 | HCPCS | Injection, interferon beta-1b, 0.25 mg | Experimental — interferon therapy |
| J9212 | HCPCS | Injection, interferon alfacon-1, recombinant, 1 mcg | Experimental — interferon therapy |
| J9213 | HCPCS | Injection, interferon, alfa-2A, recombinant, 3 million units | Experimental — interferon therapy |
| J9214 | HCPCS | Injection, interferon, alfa-2B, recombinant, 1 million units | Experimental — interferon therapy |
| J9215 | HCPCS | Injection, interferon, alfa-N3 (human leukocyte derived), 250,000 IU | Experimental — interferon therapy |
| J9216 | HCPCS | Injection, interferon, gamma 1-b, 3 million units | Experimental — interferon therapy |
| Q3027 | HCPCS | Injection, interferon beta-1a, 1 mcg for intramuscular use | Experimental — interferon therapy |
| Q3028 | HCPCS | Injection, interferon beta-1a, 1 mcg for subcutaneous use | Experimental — interferon therapy |
| Q5103 | HCPCS | Injection, infliximab-dyyb, biosimilar (Inflectra), 10 mg | Experimental — anti-TNF biosimilar |
| Q5104 | HCPCS | Injection, infliximab-abda, biosimilar (Renflexis), 10 mg | Experimental — anti-TNF biosimilar |
| Q5109 | HCPCS | Injection, infliximab-qbtx, biosimilar (Ixifi), 10 mg | Experimental — anti-TNF biosimilar |
| Q5140 | HCPCS | Injection, adalimumab-fkjp, biosimilar, 1 mg | Experimental — anti-TNF biosimilar |
| Q5141 | HCPCS | Injection, adalimumab-aaty, biosimilar, 1 mg | Experimental — anti-TNF biosimilar |
| Q5142 | HCPCS | Injection, adalimumab-ryvk, biosimilar, 1 mg | Experimental — anti-TNF biosimilar |
| Q5143 | HCPCS | Injection, adalimumab-adbm, biosimilar, 1 mg | Experimental — anti-TNF biosimilar |
| Q5144 | HCPCS | Injection, adalimumab-aacf (Idacio), biosimilar, 1 mg | Experimental — anti-TNF biosimilar |
| Q5145 | HCPCS | Injection, adalimumab-afzb (Abrilada), biosimilar, 1 mg | Experimental — anti-TNF biosimilar |
| S0145 | HCPCS | Injection, pegylated interferon alfa-2a, 180 mcg per ml | Experimental — interferon therapy |
| S0148 | HCPCS | Injection, pegylated interferon alfa-2b, 10 mcg | Experimental — interferon therapy |
| S9359 | HCPCS | Home infusion therapy, anti-tumor necrosis factor intravenous therapy (e.g., infliximab) | Experimental — anti-TNF home infusion |
| S9559 | HCPCS | Home injectable therapy; interferon, including administrative services | Experimental — interferon home therapy |
Key ICD-10-CM Diagnosis Codes
| Code | Description |
|---|---|
| M72.0 | Palmar fascial fibromatosis (Dupuytren's) — when criteria are met |
| M24.541 | Contracture, right hand |
| M24.542 | Contracture, left hand |
| M24.543 | Contracture, right wrist |
| M24.544 | Contracture, left wrist |
| M24.545 | Contracture, right finger |
| M24.546 | Contracture, left finger |
| M24.547 | Contracture, right thumb |
| M24.548 | Contracture, left thumb |
| M24.549 | Contracture, hand, unspecified |
Note: The policy data also lists ICD-10 codes D25.0–D25.9 (leiomyoma of uterus). These appear to be a data error in the source document—they are unrelated to Dupuytren's contracture. Do not use D25.x codes for Dupuytren's billing. Use M72.0 and the appropriate M24.54x laterality code.
Get the Full Picture for CPT 26040
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.